COMP <GO>
ONC vs GMAB // RETURN ON INVESTED CAPITAL (ROIC)
BeOne Medicines Ltd. (NASDAQ) VS. Genmab A/S ADS (NASDAQ) • 15-METRIC TALLY: ONC 6
— GMAB 6
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: ONC
LAST: $371.56 (-0.48%) • MKT CAP: $42.25B
roic
10.50%
LAST: $56.49 (-1.40%) • MKT CAP: $35.25B
roic
9.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ONC VS. GMAB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ONC | GMAB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 87.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 10.50% | 9.90% | +0.60 | ONC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 63.9x | 21.0x | +42.90 | GMAB | /valuation <GO> |
| Free Cash Flow Yield | 2.23% | 2.21% | +0.02 | ONC | /fcf-yield <GO> |
| Operating Margin | 8.40% | 13.90% | -5.50 | GMAB | /operating-margins <GO> |
| Net Profit Margin | 5.40% | 10.90% | -5.50 | GMAB | /net-margins <GO> |
| Revenue Growth (YoY) | 40.20% | 22.00% | +18.20 | ONC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.68 | 3.74 | +2.94 | ONC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | ONC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.6 | 85.2 | -31.60 | GMAB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 1.09 | -0.11 | GMAB | /macro-sensitivity <GO> |
| Forward P/E Multiple | 123.6x | 27.6x | +96.00 | GMAB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $42.25B | $35.25B | $6.99B | ONC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ONC REV | GMAB REV | ONC GROSS % | GMAB GROSS % | ONC FCF | GMAB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.34B | — | 87.5% | — | $941.7M | — |
| FY 2024 | $3.81B | — | 84.4% | — | -$633.3M | — |
| FY 2023 | $2.46B | — | — | — | -$1.27B | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ONC // BETA 0.98
GMAB // BETA 1.09